Chargement en cours...
Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole
This study evaluated the effects of cytochrome P450 (CYP) 2C19 polymorphisms on tacrolimus pharmacokinetics when coadministered with voriconazole. Eighteen healthy volunteers, including 6 individuals in each CYP2C19 genotype (extensive metabolizers [EMs], intermediate metabolizers [IMs], and poor me...
Enregistré dans:
| Publié dans: | J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5057355/ https://ncbi.nlm.nih.gov/pubmed/26239045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.605 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|